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ARTICLE
The heterodimeric structure of heterogeneous nuclear
ribonucleoprotein C1/C2 dictates 1,25-dihydroxyvitamin
D-directed transcriptional events in osteoblasts
Thomas S Lisse1,2, Kanagasabai Vadivel1, S Paul Bajaj1, Rui Zhou1, Rene F Chun1, Martin Hewison1 and John S Adams1
Heterogeneous nuclear ribonucleoprotein (hnRNP) C plays a key role in RNA processing but also exerts a
dominant negative effect on responses to 1,25-dihydroxyvitaminD (1,25(OH)2D) by functioning as a vitaminD
response element-binding protein (VDRE-BP). hnRNPC acts a tetramer of hnRNPC1 (huC1) and hnRNPC2
(huC2), and organization of these subunits is critical to in vivo nucleic acid-binding. Overexpression of either
huC1 or huC2 in human osteoblasts is sufficient to confer VDRE-BP suppression of 1,25(OH)2D-mediated
transcription. However, huC1 or huC2 alone did not suppress 1,25(OH)2D-induced transcription in mouse
osteoblastic cells. By contrast, overexpression of huC1 and huC2 in combination or transfection with a
bone-specific polycistronic vector using a ‘‘self-cleaving’’ 2A peptide to co-express huC1/C2 suppressed
1,25D-mediated induction of osteoblast target gene expression. Structural diversity of hnRNPC between
human/NWPs andmouse/rat/rabbit/dogwas investigated by analysis of sequence variationswithin the hnRNP
CLZ domain. The predicted loss of distal helical function in hnRNPC from lower species provides an
explanation for the altered interaction between huC1/C2 and theirmouse counterparts. These data provide new
evidence of a role for hnRNPC1/C2 in 1,25(OH)2D-driven gene expression, and further suggest that
species-specific tetramerization is a crucial determinant of its actions as a regulator of VDR-directed
transactivation.
Bone Research (2014) 2, 14011; doi:10.1038/boneres.2014.11; published online: 01 July 2014
INTRODUCTION
1, 25-dihydroxyvitamin D [1,25(OH)2D] is the active form of
vitamin D in target tissues such as bone. Upon interaction
with its cognate intracellular receptor, vitamin D receptor
(VDR), and dimerizing with the unliganded retinoid X
receptor (RXR), the 1,25(OH)2D–VDR–RXR complex acts
to transregulate the expression of genes by directly bind-
ing to specific vitamin D response elements (VDREs). This
binding event influences transcription of vitamin D-
responsive genes via concerted interaction of the acti-
vated VDR with the chromatin remodeling apparatus as
well as with receptor co-activators and co-repressors in
the transcriptional machinery of the cell that ultimately
control the diverse physiological actions of vitamin D.1–4
In previous studies we have described an additional reg-
ulatory component of intracellular 1,25(OH)2D–VDR–RXR
signaling involving alternatively spiced members of the
heterogeneous nuclear ribonucleoprotein C family of
nucleic acid binding proteins (hnRNP1 and hnRNP C).5–9
hnRNPs are abundantly expressed nucleocytoplasmic
shuttle proteins that share a wide array of nucleic acid
and protein targets that impact a multitude of cellular
and molecular functions throughout the cell.10–12 For
example, the functional hnRNPC1/C2 tetramer
(C13C21)
13–14 is known to play a role in (i) chromatin remo-
deling;15 (ii) the early steps of spliceosome assembly and
pre-mRNA splicing;16–17 and (iii) in modulating the stability,
export and level of translation of bound mRNA molecules
by interacting with the 59-UTR of mRNAs and non-coding
RNAs.18–19 Although classically characterized as a RNA
binding and regulating protein, hnRNPC1/C2 can also
interact with double-stranded DNA. In chromatin immuno-
precipitation studies we have shown that hnRNPC1/C2
binds to VDREs in the absence of the VDR, with
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hnRNPC1/C2-VDRE occupancy being displaced by the
1,25(OH)2D-bound VDR–RXR complex.
8 In this capacity
hnRNPC1/C2 functions as a dominant-negative-acting
VDRE-binding protein (VDRE-BP). This action of hnRNPC1/
C2 appears to contribute to normal VDR signaling capacity
by occupying VDREs in the basal state and by participating
in reciprocal cyclical VDRE binding following exposure to
the VDR-activating ligand, 1,25(OH)2D. This reciprocal rela-
tionship between VDR and hnRNPC1/C2 is disrupted when
the VDRE-BP is overexpressed, leading to 1,25(OH)2D insens-
itivity in the target cell.8,20–23 In vivo, over-expression of
hnRNPC1/C2 has been associated with vitamin D-resistant
rachitic bone disease in vitamin D-deprived New World pri-
mates24 and in man.7 Based on these molecular and
phenotypic observations, the aim of the present study
was to recapitulate and translate the VDRE-BP-induced
vitamin D-resistant state in human bone cells by developing
and characterizing murine osteoblastic cell lines which
stably over express tetrameric HNRNPC proteins.
MATERIALS AND METHODS
Reagents and cell culture
Crystalline 1,25(OH)2D (Biomol, Plymouth Meeting, PA,
USA) was reconstituted in absolute ethanol. Cells were
treated with 0–10 nmol?L21 of 1,25(OH)2D incubated in
the respective media with 1% FCS. MC3T3-E1 murine
and MG63 human osteoblastic cells (both ATCC,
Manassas, VA, USA) were maintained in a-MEM plus
10% FBS and incubated at 37 6C in a 95% air/5% CO2
atmosphere until 80%–90% confluent and then pas-
saged. The J774A.1 mouse monocyte/macrophage cell
line (ATCC) was cultured in DMEM with 10% FCS. For over-
expression studies, the hnRNPC1 and C2 constructs were
previously cloned and ligated into the pCDNA 3.1/V5-His-
TOPO vector (Invitrogen, Grand Island, NY, USA8); the
constructs were transfected using the BioT reagent
(Bioland Scientific, Paramount, CA, USA) in 12-well tissue
culture plates (0.1–1.0 mg per well total recDNA). Cells
were analyzed at designated time points post transfec-
tion or transduction.
Cell fractionation and Western blot
Treated cells were harvested and washed with ice-cold
phosphate-buffered saline. Cell lysates were prepared in
RIPA buffer with 1 X ProteoBlock protease inhibitor cocktail
(Fermentas, Glen Burnie, MD, USA) and 1 mmol?L21 PMSF.
For separation of nuclear and cytoplasmic fractions for
extraction, the NE-PER nuclear and cytoplasmic extrac-
tion kit (Thermo Fisher Scientific Inc., Rockford, IL, USA)
was utilized. Protein samples (20 mg) were separated by
SDS-PAGE. Primary anti-hnRNP C1/C2 (sc-32308; Santa
Cruz Biotechnology, Santa Cruz, CA, USA) and secondary
antibodies were used at 1 : 1 000. I-Block2 blocking
reagent (Applied Biosystems, Foster City, CA, USA) was
used during incubation steps.
Real-time quantitative PCR analysis
RNA was prepared using the RNeasy minikit (Qiagen Inc.,
Valencia, CA, USA). cDNA was synthesized by SuperScript
Reverse Transcriptase III (Invitrogen) utilizing random hex-
amers. Quantitative PCR analysis was performed with a
Stratagene MX-3005P instrument utilizing TaqManH system
reagents from Applied Biosystems (Supplementary
Table S1). Target genes were normalized to 18S rRNA
expression. All cDNAs were amplified under the following
conditions: 50 6C for 2 min; 95 6C for 10 min followed by 40
cycles of 95 6C for 15 s and 60 6C for 1 min. All reactions
were performed in triplicate.
Bicistronic human hnRNPC1 and C2 vector construction
Construct pRRL-sin-cPPT-mouse (mu) col1a1 2.3 kb pro-
moter-IRES-GFP-hPGK-puromycin was produced by PCR
of mu pcol1a1 with XbaI at the 59 end (primer 5-col1a1-
XbaI (Supplementary Table S2)) and blunted at the 39 end
(primer 3-col1a1-MluI) prior to digestion. The mouse col1a1
2.3 kb promoter was kindly provided by Benoit de
Crombrugghe (Univ. Texas, M. D. Anderson Cancer
Center). Construct pRRL-sin-cPPT-mu col1a1 2.3 kb pro-
moter-human (hu) hnRNPC1-IRES-GFP-hPGK-puromycin
was produced by PCR of hu hnRNPC18 with a MluI site at
the 59 end (primer 5-hu hnRNPC1-MluI) and EcoRI at the 39
end (primer 3-hu hnRNPC1-EcoRI). The products were then
digested and ligated into pRRL-sin-cPPT-mu col1a1 2.3 kb
promoter-IRES-GFP-hPGK-puromycin cut with MluI and
EcoRI. Construct pRRL-sin-cPPT-mu col1a1 2.3 kb pro-
moter-hu hnRNPC1-P2A-hu hnRNPC2-IRES-GFP-PGK-puro-
mycin was produced by PCR of hu hnRNPC2 blunted at
the 59 end (primer 5-hu hnRNPC2) and with ClaI at the 39
end (primer 3-hu hnRNPC2-ClaI). This product was then
digested and ligated with pRRL-sin-cPPT-CMV-GFP-P2A-
MCS cut with SmaI and EcoRI. This plasmid was then used
to PCR P2A-hu hnRNPC2 blunted at the 59 end (primer 5-
P2A) and with EcoRI at the 39 end (primer 3-hu hnRNPC2-
EcoRI). PCR of hu hnRNPC1 was produced with EcoRI at
the 59 end (primer 5-hu hnRNPC1-EcoRI) and blunted with-
out the stop codon at the 39 end (primer 3-hu hnRNPC1-
(-TAA)). Both were digested and ligated into plasmid
pRRL-sin-cPPT-mu col1a1 2.3 kb promoter-IRES-GFP-
hPGK-puromycin digested with EcoRI. Corresponding
empty vectors were also constructed.
Lentiviral production and transduction
Lentiviral production was performed for construct pRRL-
sin-cPPT-mu col1a1 2.3 kb promoter-hnRNPC1-IRES-GFP-
hPGK-puromycin. The construct pMD.G was used for the
production of the VSV-G viral envelope in combination
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with the packaging constructs pHit6025 and the pBabe
constructs correspond to the different transfer vectors.
Briefly, 100 mm dishes of nonconfluent 293T cells were
cotransfected with 6.5 mg of pHit60, 3.5 mg of pMDG
(encoding the VSV-G envelope) and 10 mg of p Babe
(hu hnRNPC1 construct), by the CaPi-DNA coprecipitation
method.26 Next day, the medium was adjusted to make a
final concentration of 10 mmol?L21 sodium butyrate and
the cells were incubated for 8 h to obtain high-titer virus
production as previously described. After the 8-h incuba-
tion, cells were washed and incubated in fresh medium
without sodium butyrate. Conditioned medium was har-
vested 16 h later and passed through 0.45 mm filters. For
transduction of MC3T3-E1 cells, cells were seeded at
83104 cells per well in 12-well plates. Transductions were
carried out in 0.5 mL DMEM, including serial dilutions of
lentiviral vector supernatant. The cells were then washed
with phosphate-buffered saline after 24 h post transduc-
tion and incubated in regular medium for 48 h.
Molecular dynamic simulations and free energy
calculations for hnRNPC
The coordinates of the human hnRNP C leucine zipper-like
oligomerization domain (CLZ) tetramer (PDB code 1TXP)27
were used for the simulations. PDB structure contains Ile at
position 180;27 to get the correct human or mouse
sequence, the Ile was mutated to Leu using the program
PyMol (http://www.pymol.org). The mouse hnRNPC tetra-
mer was built by mutating the residue Asn200 to Ser.
Molecular dynamics simulations were performed in explicit
water using NAMD28 with CHARMM27/CMAP force field.29
The tetramers were solvated in a cubic TIP3P solvent box of
9.0 Å. Periodic boundary conditions, Particle Mesh Ewald
summation and SHAKE-enabled 2-femto seconds time
steps were used in all molecular dynamics simulations.
Initial configurations were subjected to a 500-step minimiza-
tion with the harmonic constraints of 10 kcal?mol21?Å22 on
the protein heavy atoms. The systems were gradually
heated from 0 to 300 K over a period of 30 ps with har-
monic constraints. The simulation at 300 K was then contin-
ued for 200 ps during which the harmonic constraints were
gradually lifted. The systems were then equilibrated for a
period of 300 ps before the 10 ns production run. All simula-
tions were carried out in the NPT ensemble. The binding free
energy of the hnRNPC2 to hnRNPC1 for the different (inter-
species) combinations was estimated using the MMPBSA
module in AMBER 9.0 (Ref. 30) by taking snapshots (2 000)
at every 5 ps from the 10-ns production run.
Data normalization and statistical analysis
The real-time quantitative PCR methodology is based
on determining the delta cycle threshold (DCt) values.
The average DCt value was taken for triplicate sets.
The fold induction was calculated by the formula:
2 avgDCt0nm{avgDCt ið Þ, where i is 0–10 nmol?L21. An analysis
of variance statistical test was conducted with a
Bonferroni multiple comparison post hoc analysis where
P#0.05 was considered statistically significant.
RESULTS
Effects of human hnRNPC1/C2 on 1,25(OH)2D-mediated
gene transactivation in mouse osteoblasts
As shown in Figure 1a, when transfected into mouse MC3T3
osteoblasts, suppression of 1,25(OH)2D-mediated transcrip-
tion was only observed when huC1 and huC2 were used in
combination. In fact, expression of Ddit4, a gene we have
previously shown to be induced by 1,25(OH)2D in osteo-
blasts,20 was enhanced not suppressed, in mouse MC3T3
cells transfected with either huC1 or huC2 alone in the pres-
ence of 1,25(OH)2D. By contrast, overexpression of either
huC1 or huC2 was sufficient to suppress 1,25(OH)2D-
induced gene expression in human MG-63 osteoblast-like
cells, with combined over-expression of huC1 and huC2
having an additive suppressive effect (Figure 1b).
To determine whether the lack of efficacy of huC1 and
huC2 individually to squelch 1,25(OH)2D-directed gene
expression was due to relatively low transfection efficiency
and subsequent expression of the human subunits in
mouse osteoblasts, similar studies were also carried out
using a bone-specific vector to drive expression of huC1
in mouse cells harboring the endogenously expressed oli-
gomerization partner, muC2 (Figure 2a and 2b). Despite
50- to 3 000-fold higher levels of expression relative to the
endogenous muC1 and muC2 expression levels, transfec-
tion with huC1 continued to have no significant effect on
1,25(OH)2D-induced gene expression (Figure 2c).
The apparent requirement for both huC1 and huC2 to
suppress 1,25(OH)2D-directed transcription in mouse
osteoblasts was further illustrated in MC3T3-transfected
cell lines where huC1 and huC2 were co-expressed under
the control of the osteoblast-specific mouse col1a1 pro-
moter. In contrast to the previous experiments, vectors
used in this part of the study encoded the huC1 and
huC2 linked to one another by the self-cleaving 23
amino-acid picornaviral 2A-like sequence from the por-
cine teschovirus-1 (P2A) to allow for efficient functional
stoichiometric expression of multiple flanking proteins
under the influence of the bone-specific col1a1 2.3 kB pro-
moter (Figure 3a31). The advantage of combined trans-
gene expression with the P2A over transgenes linked by
an internal ribosomal entry site or introduced by individual
constructs is its independence of copy number required
for integration, its relatively small size and its high cleavage
efficiency.32 Using this system, both the huC1 and huC2
isoforms were equally overexpressed specifically in the
nuclear compartment of MC3T3 cells (Figure 3b). The
Vitamin D and hnRNPC1/C2
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efficiency of transfection of the single open reading frame
was assessed by green fluorescent protein (GFP) express-
ion within various cell lines (Figure 4a), and the absence of
uncleaved product in Western blot analyses indicated effi-
cient cleavage of the P2A protein (Figure 4b). Cell (tissue)-
specific expression of huC1/huC2 was confirmed by par-
allel analysis of the temporal pattern of endogenous
mouse Col1a1 mRNA levels over time in MC3T3 bone cells,
but not J774A mouse monocytes (24–96 h) (Figure 5).
As shown in Figure 3c, co-expression of huC1 and huC2
using the P2A vector acted as a dominant-negative inhib-
itor of 1,25(OH)2D-induced expression of Cyp24a1 and
Ddit4 target genes in mouse osteoblasts. Endogenous
muC1/muC2 transcript levels were unchanged under
both basal and 1,25(OH)2D-treated conditions (Figure 6),
suggesting no interference by endogenous mouse
hnRNPC protein subunits.
Species-specific variations in the structure of the hnRNPC
oligomerization domains dictate function
The hnRNPC proteins associate with RNA as tetramers with
a composition of three hnRNP C1 subunits and one hnRNP
C2 subunit (C13–C21). Studies in vivo have shown that the
formation of the tetrameric complex, which is highly stable
in solution, is driven by a 28-residue helical region (residues
180–207) referred to as hnRNPC leucine zipper-like (CLZ)
oligomerization domain27 (Figure 7a). The CLZ domain
promotes the oligomerization by forming a coiled coil tet-
ramer structure; hnRNPC proteins possessing mutations in
the CLZ domain bind weakly to nucleic acid substrates.27
Amino-acid sequences of the hnRNPC CLZ oligomeriza-
tion domain are well conserved within vertebrates, exhib-
iting 74%–98% identity to the human CLZ domain
(Figure 7b). Like many oligomerizing proteins, hnRNPC
isoforms employa-helical coiled coils as an oligomerization
mechanism with the parts stabilized by continuous inter-
helical contacts formed between hydrophobic faces of
amphipathic helices.33 For each set of seven residues
(heptad) along the helix (denoted a–g; Figure 7b), the
contact geometry is repeated for the ideal coiled coil.
Hydrophobic residues occupying the a and d heptad
positions form interhelical contacts in the coiled coil core
as well as other contact surfaces at interfacial e and g
heptad positions. Comparison of the human and mouse
hnRNPC sequences in Figure 7b revealed that the Ser at
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Figure 1. Effects of overexpressed human hnRNPC1 and C2 on VDR-mediated gene transcription in human and mouse osteoblast-like cells. Effect of
overexpression of human hnRNPC1 (C1) and/or human hnRNPC2 (C2) on 1,25(OH)2D-induction of the vitamin D-target genes CYP24A1/Cyp24a1
and DDIT4/Ddit4 in (a) mouse MC3T3 osteoblastic cells and (b) human MG-63 osteoblastic cells. Cells were treated with or without 10 nmol?L21
1,25(OH)2D for 6 h, 24 h post transfection with either empty vector (c), C1, C2 or C1 and C2 (C1/C2). Data show mean6s.d. (n53 separate cultures)
fold-change inmRNA expression forCYP24A1/Cyp24a1 andDDIT4/Ddit4 for each transfected cell type following treatmentwith 1,25(OH)2D relative
to vehicle-treated control cells. ***P,0.001, statistically different from empty vector controls (C), **P,0.01, statistically different from C.
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such, the most distal interfacial g position heptad of the
hnRNPC CLZ domain used for hnRNPC1–hnRNPC2 oligo-
merization in the mouse is disrupted.
Free energy and stability analysis of tetramers formed by
combinations of mouse and human hnRNPC1/C2
To determine whether interaction between the Asp-200 in
the human and Ser-200 in the mouse hnRNPC protein was
sufficient to cause destabilization of the CLZ-coiled
hnRNPC1/C2 tetramer, the binding free energy of inter-
species tetramers harboring three hnRNPC1 and one
hnRNPC2 subunit combinations, huC13–muC21and
muC13–huC21, was calculated using the MMPBSA method
implemented in Amber 9.0. When calculating the binding
free energy, the holotetramer was considered as a com-























































































































































































Figure 2. Stable expression of only humanhnRNPC1protein inmouseMC3T3-E1 osteoblasts does not confer resistance to 1,25(OH)2D. (a) Osteoblastic
transduction was performed using the lentivirus RRL transfer vector harboring a stop codon-less human (hu) hnRNPC1 cDNA and a GFP cassette
driven by the bone-specific mouse col1a1 2.3 kB promoter. The lentivector backbone also contains the cPPT from the HIV-1 integrase gene to increase
the copy number of lentivirus integrating into the host genome to enhance viral titer. (b) FACS sorting of GFP-positive MC3T3-E1 osteoblasts
transduced with the hu hnRNPC1 and empty lentivirus vectors for the isolation and generation of stable clones. (c) Fifteen hu hnRNPC1-over-
expressing stable lines were created (data not shown), whereby five (clones 39, 59, 89, 109, 119) lines with variable hnRNPC1 overexpression were
further evaluated for 1,25(OH)2D (10 nmol?L21, 6 h) mediated induction of endogenous mouse (mu) Cyp24a1mRNA. cPPT, central polypurine tract.
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hnRNPC2 subunit and its CLZ domain as a binding ligand
partner. In all cases, the negative binding free energy indi-
cated favorable interactions between the C13 and C21
CLZ domains regardless of the species derivation of the
subunits. As shown in Table 1, the highest negative binding
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Figure 3. Equimolar expression of human hnRNPC1 and C2 confers resistance to 1,25(OH)2D in mouse MC3T3-E1 osteoblasts. (a) Schematic repres-
entation of the mouse col1a1 2.3 kB promoter-driven piconoviral P2A sequence construct for the co-expression of human (hu) hnRNPC1 and C2
proteins with a GFP reporter. (b) Western blot analyses showing overexpression of hnRNPC1 and C2 proteins using the P2A construct enriched in the
nuclear fraction of MC3T3-E1 cells at 96 h post transfection. Empty vector (E), and high (H, 2 mg per well) and low (L, 0.1 mg per well) levels of P2A
expression vector cDNA were transfected into MC3T3 cells. (c) 1,25(OH)2D (0.1–10 nmol?L21; 6 h) induction of mouse osteoblastic genes after





































Figure 4. Efficient transfection of the P2A hnRNPC1/C2 construct. (a) Transient transfection of P2A hnRNPC1/C2 construct with IRES-GFP reporter
shows efficient labeling of both J774A.1 mouse monocytic andMC3T3-E1 osteoblastic cells after 96 h post transfection. The empty vector control also
depicts efficient and comparable GFP labeling. (b) Western analysis of whole cell lysate for beta-actin and hnRNPC1/C2 expression 96 h post
transfection.
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the additional favorable interactions that could occur
between Asn-200 and Glu-186 in the tetramer (Figure 7c,
left panel). By contrast, only one hydrogen bond is possible
for the muC13–huC21 complex (Figure 7c, right panel),
providing a potential explanation for the relatively low
negative binding energy for the mouse hnRNPC1/C2 tet-
ramer. The negative free energy of the interspecies oligo-
meric combinations, muC13–huC21 (2107.22 kcal?mol
21)
and huC13–muC21 (2103.25 kcal?mol
21), were intermedi-
ate to the species-specific tetramers (Table 1). These
results indicate that the Asn-200 in the human hnRNPC
CLZ domain plays a pivotal role in stabilization of the
hnRNPC1/C2 oligomer in man. To assess the potential
impact of hnRNPC subunit binding energy variations on
tetramer stabilization, molecular dynamic simulations
were carried out (Figure 7d). Data are shown as the root
mean square deviations for the backbone atoms (N–CA–
C–O) from the experimental structure, over 10 ns for the
four tetrameric combinations depicted in Table 1. The
huC13–muC21 interspecies tetramer complex showed
large fluctuations (instability) during the initial phases of
the 10-ns period of simulation, but eventually reached a
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Empty (1 mg)
Untransfected
Figure 5.Cell type-specific action and temporal regulation of the P2A hnRNPC1/C2 construct. (a) Endogenousmouse (mu) type I collagen expression
was monitored over a 96-h period under the different transient transfection conditions. For both transfected constructs into MC3T3-E1 cells, col1a1
mRNA expression was delayed when compared to the untransfected controls. In J774A.1 mouse monocytes the expression of endogenous mu type I
collagenwas variable between the transfected P2A construct and untransfected control, and unregulated in the empty vector control. (b) Human (hu)
hnRNPC mRNA levels were monitored in the mouse col1a1 promoter-driven P2A construct-transfected cells at 96 h post transfection. Hu hnRNPC
mRNAwas temporally regulated in a similar fashion as mu type I collagen in MC3T3-E1 osteoblasts. No temporal regulation of huhnRNPC mRNA
was observed in J774A.1mumonocytes transfectedwith the P2A construct, suggesting themu col1a1 2.3 kB promoterwas bone-specific. (c) After 96 h
of transfection, MC3T3-E1 cells harboring the P2A hnRNPC1/C2 construct express huhnRNPC with mRNA levels approximately 125-fold higher





























Figure 6. Endogenous mouse hnRNPC not responsible for functional
effects. Endogenous mouse (mu) hnRNPC expression was monitored
in MC3T3-E1 cells after transfection and 6-h treatment with various
concentrations of 1,25(OH)2D.
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DISCUSSION
The goal of the present study was to develop a mouse
model that recapitulated the hnRNPC1/C2 (VDRE-BP)
overexpression-induced vitamin D-resistant state
observed in vivo in the skeletons of growing nonhuman
and human primates.7 Before developing the animal
model, we assessed the effects of hnRNPC1/C2
overexpression using a mouse osteoblast cell line. The
studies here show that overexpression of huC1 and huC2
in combination or transfection with a bone-specific, poly-
cistronic vector suppressed transspecies 1,25(OH)2D-
mediated induction of mouse osteoblast target gene
expression. This finding suggests that human hnRNPC1/
C2 can function as a dominant-negative-acting inhibitor
HNRNPC
Isoform C2 (306aa; 8 exons) - Canonical
RNA-recognition motif 13aa
16 87107 119 155 181 303161
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RNA-recognition motif NLS Auxiliary domain






heptad: –a fd ecb g –a fd ecb g a fd ecb a bg
human [Homo sapiens]
















0 10 0009 0008 0007 0006 0005 000
Time/ps


























Figure 7. hnRNPC1/C2 tetramer stability based on species-specific amino-acid substitutions. (a) Schematic representation of human hnRNPC iso-
forms. Each protein contains a single RRM, a delineatedNLS, a bZLMand an encompassing acidic auxiliary domain. hnRNPC2 contains an additional
13 aa and is expressed at one-third the level of hnRNPC1. An oligomerization domain (CLZ) is also present in C proteins. Numbers represent aa
position. (b) Alignment of CLZ sequences derived from the Ensembl database (http://www.ensembl.org). Key asparagine (N) to serine (S) change
within the mouse sequences occupying an interhelical contact surface heptad residue within the coiled coil core of hnRNP C. Similar residues are
highlighted in black, while discrepant residues are highlighted in white. The heptad arrangement is in italics, with the key intermolecular residues
forming antiparallel chain contacts underlined and bolded. Numbering based on the human C2 full-length isoform. (c) The hnRNPC protein CLZ
tetramers of Hu andMuC1 and C2 proteins. HuC13–HuC21 (left panel) andMuC13–HuC21 (right panel). The Asn200, Ser200 andGlu186 residues are
shown in stick representation. InHuC13–HuC21 CLZdomains, pairs from the adjacent helicesmake four hydrogen bonds in the coiled coil tetramer. In
contrast, in the MuC13–HuC21 tetramer, only one hydrogen bond is possible. The hydrogen bonds formed between Asn200 and Glu186 are shown in
dashed lines. (d) Molecular dynamic simulations for CLZ tetramers. The root mean square fluctuations for the backbone atoms of the tetramer
complexes for different combinations of human (Hu) and mouse (Mu) hnRNPC1 and C2. HuC13–HuC21, red; HuC13–MuC21, green; MuC13–
HuC21, blue; and MuC13–MuC21, magenta. Data are based on experimental structure over 10-ns simulations. bZLM, basic leucine zipper-like motif;
NLS, nuclear localization signal; RRM, RNA recognition motif.
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of 1,25(OH)2D-driven gene expression in mouse bone cells
and that species-specific tetramerization is a critical deter-
minant of its actions as a regulator of VDR-directed trans-
activation.
A monomer of the hnRNPC protein has a primary struc-
ture that is common to hnRNPs and which can be divided
into four distinct domains: (i) the RNA recognition motif
consisting of beta-sheets; (ii) the basic high affinity RNA
binding domain or basic leucine zipper-like motif, residues
180–207; (iii) the leucine zipper containing four heptad
repeats toward the carboxyl-terminus (CLZ); and (iv) the
negatively charged carboxyl-terminal domain (CTD).34–35
It is the basic leucine zipper-like motif domain, rather than
the RNA recognition motif, which plays the major role in
binding to pre-mRNA and snRNA with high affinity.36 Based
on detailed sequence-specific labeling and solution struc-
tural analyses, the current model suggests that hnRNPC
proteins exist in an anti-parallel four-helix tetrameric bun-
dle which is centrally positioned and that these bundles
assemble through highly stable associations of their leu-
cine zipper CLZ domains.27,37 The human and mouse CLZ
domains are well conserved with the only difference being
an Asp to Ser change at the terminal helix of the coiled coil
structure (Figure 7b). The CTD is thought to be involved in
protein–protein interactions that serve to increase specifi-
city of nucleotide binding. Although there is increasing
awareness of the composition, function and mechanisms
associated with hnRNPC and homologous proteins, the
protein–protein interactions that participate in their
recruitment to cis elements along genomic DNA have
yet to be fully defined. Emerging evidence shows that
the CTD of hnRNPs interacts with transcription elongation
factors, chromatin-modifying complexes and pre-mRNA
maturation enzymes, thus providing a molecular basis for
the coupling between gene transcription and RNA pro-
cessing.15 While the hnRNPC protein domain responsible
for interaction in cis with VDREs regulated expression of
1,25(OH)2D-driven target genes remains uncertain, our
modeling indicates that the DNA transbinding domain
may be located within a hinge portion of the acidic CTD.
This would place it apart from the core bundle stabilization
domain known to bind cis elements which vary among
higher and lower mammalian species.15,37
hnRNPs were first recognized for their ability to bind to
single-stranded RNA.10,38–39 However, it was subsequently
determined that hnRNPs have the ability to bind both sin-
gle- and double-stranded DNA5,7,15 with specific cis-act-
ing DNA sequences being important determinants in
transcriptional regulation of gene expression under the
control of steroid hormone receptors such as VDR and
the estrogen receptor.9 In the current study, overexpres-
sion of either huC1 or huC2 in human osteoblasts was suf-
ficient to suppress 1,25(OH)2D-VDR-mediated signaling.
Unexpectedly, repression of 1,25(OH)2D–VDR–VDR-direc-
ted transcription was only achieved by co-overexpression
of both huC1 and huC2 in murine osteoblasts. These data,
together with molecular dynamic simulation analyses pre-
sented in Figure 7, suggest that optimal DNA binding and
the subsequent dominant-negative action of hnRNPC1/
C2 on transcription occurs with species-specific tetramer-
ization patterns involving the C1 and C2 isoforms
(Figure 7). Binding free energy modeling further suggests
that this differential response is due to subtle variations in
the protein–protein interactions required for hnRNPC1/C2
tetramerization.
While the computational molecular dynamic studies
presented here showed that interspecies tetramers of C1
and C2 can form (Figure 7), it is also known that tetramer
stability is influenced by elements in the negatively
charged CTD of hnRNPC that have diverged most
between mouse and man.36 For example, a deletion con-
struct of the human hnRNPC lacking the CTD beyond the
leucine zipper can exist as a dimer,37 highlighting the
importance of this region of hnRNPC protein for tetramer
assembly. Further, velocity sedimentation analysis of dele-
tion constructs of the hnRNPC CTD demonstrates that the
residues between S-240 and G-263 play a critical role in the
native tetramer formation and stabilization.37 Interestingly,
the only proximal variation between mouse and human
sequences within the CTD is at amino-acid position
242, where mouse harbors an alanine and humans a gly-
cine (data not shown), suggesting that differences in the
hydropathy index of that portion of the CTD may alter CTD-
dependent functions. Importantly, site-specific mutagen-
esis experiments that either removed or reversed the
charges at specific residues within this proximal CTD
resulted in a decrease in tetramer assembly.37 Either lysine
or alanine (non-charged) substitutions significantly attenu-
ated tetramer assembly; the mouse harbors an alanine at
position 242 in the CTD of hnRNPC. These observations sug-
gest that the incompletely conserved CLZ domain and the
carboxyl-terminal half of the CTD between mouse and
man may disturb the function of hnRNPC by affecting sub-
unit oligomerization and by altering interactions between
the non-homologous residues of the CTD and the four-helix
bundle of native hnRNPC proteins. With these observations
Table 1. Binding free energy of the hnRNPC CLZ domain according to
tetramer combinations of mouse and human hnRNPC1 and C2. The
total binding free energy for different combinations of human (hu)
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in mind, we postulate that changes in the helix-interaction
structures of hnRNPC tetramers can fundamentally alter its
binding affinity for cis elements controling 1,25(OH)2D–
VDR-driven target genes.
It is clear that the full range of hnRNPC activities has not
been elucidated. For example, members of the hnRNPC
family can bind single-stranded DNA,40 suggesting that
they may have distinct roles in DNA replication and recom-
bination events as well as in transcription and transcript
handling. The identification of species-specific cellular
functions of hnRNPC proteins and their specific DNA targets
will greatly help to elucidate the broader role of this versat-
ile nuclear protein, in particular its role in vitamin D physi-
ology and diseases that are marked by relative degrees of
target tissue resistance to active vitamin D metabolites.
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